These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1666791)

  • 1. A new design for truly self-shielding baby-cyclotrons for production of positron emitters.
    Abs M; Bol JL; Chevalier A; Conard E; Jongen Y; Ladeuze M; Lannoye G; Laycock SC; Le Docte T; Morelle JL
    Acta Radiol Suppl; 1991; 376():74-5. PubMed ID: 1666791
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclotron targetry for production of short-lived positron emitters.
    Schlyer DJ
    Acta Radiol Suppl; 1991; 376():11-4. PubMed ID: 1666737
    [No Abstract]   [Full Text] [Related]  

  • 3. High intensity H- cyclotrons for radioisotope production.
    Bol JL; Chevalier A; Conard E; Jongen Y; Ladeuze M; Lannoye G; Le Docte T; Lacroix M; Ninane A; Ryjckewaert G
    Acta Radiol Suppl; 1991; 376():76-8. PubMed ID: 1666792
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of depth distributions of (3)H and (14)C induced in concrete shielding of an electron accelerator facility.
    Endo A; Harada Y; Kawasaki K; Kikuchi M
    Appl Radiat Isot; 2004 Jun; 60(6):955-8. PubMed ID: 15110362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shielding design for multiple-energy linear accelerators.
    Barish RJ
    Health Phys; 2014 May; 106(5):614-7. PubMed ID: 24670911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The refined shielding design for the cyclotron room of the Buddhist Tzu Chi General Hospital.
    Sheu RD; Chen CC; Sheu RJ; Kao CH; Jiang SH
    Radiat Prot Dosimetry; 2005; 115(1-4):216-21. PubMed ID: 16381715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclotrons for medical use: characteristics and installation aspects.
    Salvadori PA; Bottigli U; Guzzardi R; Crouzel C; Comar D
    J Nucl Med Allied Sci; 1982; 26(1):41-54. PubMed ID: 7108636
    [No Abstract]   [Full Text] [Related]  

  • 8. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation protection and shielding design--strengthening the link.
    Hobson J; Cooper A
    Radiat Prot Dosimetry; 2005; 115(1-4):251-3. PubMed ID: 16381722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation safety review for 511-keV emitters in nuclear medicine.
    Dell MA
    J Nucl Med Technol; 1997 Mar; 25(1):12-7; quiz 33. PubMed ID: 9239598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of longer-lived positron emitters at the Paul Scherrer Institute.
    Weinreich R; Schwarzbach R; Huszar I; Smith-Jones PM
    Acta Radiol Suppl; 1991; 376():68. PubMed ID: 1666787
    [No Abstract]   [Full Text] [Related]  

  • 12. Shielding design for a laser-accelerated proton therapy system.
    Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
    Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spallation Neutron Source (SNS) project: a fertile ground for radiation protection and shielding challenges.
    Gallmeier FX; Ferguson PD; Popova II; Iverson EB
    Radiat Prot Dosimetry; 2005; 115(1-4):23-32. PubMed ID: 16381678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a flattening filter free linear accelerator on structural shielding design.
    Jank J; Kragl G; Georg D
    Z Med Phys; 2014 Mar; 24(1):38-48. PubMed ID: 23763984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Groundwater activation at the Superconducting Super Collider: a new design model.
    Bull JS; Romero VD; Baker SI; Stapleton GB; Goss DL; Coulson LV
    Health Phys; 1997 Nov; 73(5):800-7. PubMed ID: 9378656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Source terms and attenuation lengths for estimating shielding requirements or dose analyses of proton therapy accelerators.
    Sheu RJ; Lai BL; Lin UT; Jiang SH
    Health Phys; 2013 Aug; 105(2):128-39. PubMed ID: 23799497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shielding for the upgraded Duke Free Electron Laser Laboratory.
    Vylet V
    Radiat Prot Dosimetry; 2005; 115(1-4):207-11. PubMed ID: 16381713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mounting devices for screening blocks on the linear accelerator--the drawbacks and modifications].
    Kober B; Müller-Sievers K; Meier H
    Strahlenther Onkol; 1991 Jul; 167(7):419-21. PubMed ID: 1858019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target station shielding issues at the spallation neutron source.
    Ferguson PD; Gallmeier FX; Iverson EB; Popova II
    Radiat Prot Dosimetry; 2005; 115(1-4):170-5. PubMed ID: 16381707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of personnel absorbed dose at production of medical radioisotopes by a cyclotron.
    Sadat-Eshkevar SM; Karimian A; Mirzaee M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):250-3. PubMed ID: 21821617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.